• Medientyp: E-Artikel
  • Titel: The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
  • Beteiligte: Lee, Tzong-Shyuan; Yen, Hwei-Chen; Pan, Ching-Chien; Chau, Lee-Young
  • Erschienen: Ovid Technologies (Wolters Kluwer Health), 1999
  • Erschienen in: Arteriosclerosis, Thrombosis, and Vascular Biology, 19 (1999) 3, Seite 734-742
  • Sprache: Englisch
  • DOI: 10.1161/01.atv.19.3.734
  • ISSN: 1079-5642; 1524-4636
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Abstract—The cytokine profile of atherosclerotic aortas from apoE-deficient mice was assessed by reverse transcriptase-polymerase chain reaction. The results clearly showed that the expression of mRNA for IL-12p40 was evident in aortas from 3-month-old apoE-deficient mice. The mRNA for IL-10 was detected in aorta from these mice at the age of 6 months, indicating that expression of IL-12 is earlier than that of IL-10 in these animals. Concurrent with IL-12p40, the mRNA for the T-cell cytokine IFN-γ, but not IL-4, was detected in aortas of mice at young and old ages. Both in situ hybridization and immunostaining further demonstrated the localization of IL-12 in macrophages of atherosclerotic lesions. Immunohistochemistry also demonstrated the expression of costimulatory molecules B7–1 and B7–2 in macrophages, suggesting that activation of T lymphocytes by macrophages may occur via surface antigens in lesions. When the immunoglobulin isotype of the antioxidized LDL antibodies in sera of apoE-deficient mice was determined, it revealed that both IgM and IgG were present. Furthermore, IgG2a is predominant and comprises ≈50% of the antioxidized LDL IgG in sera from young mice (3 months), but decreased to lower levels (35%) in older mice (6 months). Daily administration of IL-12 led to an increase in serum levels of antioxidized LDL antibodies and accelerated atherosclerosis in young apoE-deficient mice compared with control mice injected with PBS alone. Taken together, these data suggest that IL-12 plays an active role in regulating the immune response during the early phase of atherosclerosis in apoE-deficient mice.